Zobrazeno 1 - 10
of 7 411
pro vyhledávání: '"R. Gunther"'
Autor:
Penny Fang, MD, MBA, Sonal S. Noticewala, MD, Susan Y. Wu, MD, Jillian R. Gunther, MD, PhD, Ethan B. Ludmir, MD, L. Jeffrey Medeiros, MD, Paolo Strati, MD, Ranjit Nair, MD, Chijioke Nze, MD, Loretta J. Nastoupil, MD, Sairah Ahmed, MD, Luis Malpica Castillo, MD, Luis Fayad, MD, Jason Westin, MD, Sattva Neelapu, MD, Christopher Flowers, MD, Auris Huen, MD, Swaminathan P. Iyer, MD, Bouthaina Dabaja, MD, Chelsea C. Pinnix, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 12, Pp 101650- (2024)
Purpose: Extranodal NK/T-cell lymphoma (ENKTCL) is rare in the Western Hemisphere and is commonly treated with combined modality therapy (CMT). Methods and Materials: We retrospectively reviewed 35 patients treated with Ann Arbor stage I/II ENKTCL be
Externí odkaz:
https://doaj.org/article/1b79041406a44fdbaeef87666f666797
Autor:
Susan Y. Wu, MD, Penny Q. Fang, MD, MBA, Ahmed Fetooh, MBBS, Gohar S. Manzar, MD, PhD, Kelsey L. Corrigan, MD, MPH, Benjamin R. Schrank, MD, PhD, Lewis Nasr, MD, MS, Dai Chihara, MD, PhD, Luis E. Malpica Castillo, MD, Ranjit Nair, MD, Raphael E. Steiner, MD, Preetesh Jain, MBBS, MD, DM, PhD, Sattva S. Neelapu, MD, Paolo Strati, MD, Loretta J. Nastoupil, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD, PhD, Jillian R. Gunther, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 12, Pp 101648- (2024)
Purpose: Definitive intent radiation therapy (RT) for early-stage mucosa-associated lymphoid tissue (MALT) lymphoma typically includes a dose of 24 to 30 Gy. While modest, these doses may have associated toxicity. For patients with indolent B-cell ly
Externí odkaz:
https://doaj.org/article/8e49e699e2d345d8915aa234f82ed81f
Autor:
Gohar S. Manzar, Elaine E. Cha, Kelsey L. Corrigan, Alison K. Yoder, Benjamin R. Schrank, Lewis F. Nasr, Dai Chihara, Luis Malpica Castillo, Ranjit Nair, Preetesh Jain, Sattva S. Neelapu, Maria A. Rodriguez, Paolo Strati, Loretta J. Nastoupil, Jillian R. Gunther, Bouthaina S. Dabaja, Chelsea C. Pinnix, Susan Y. Wu, Penny Q. Fang
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundDiffuse large B-cell lymphoma (DLBCL) involving the gastrointestinal (GI) organs is rare, and real-world outcomes after combined modality therapy (CMT) with systemic therapy (ST) and radiotherapy (RT) are not well-characterized, particularl
Externí odkaz:
https://doaj.org/article/df84bc152914455598065c60f0d5222a
Autor:
Booth, David
Publikováno v:
Technometrics, 2010 Aug 01. 52(3), 364-364.
Externí odkaz:
https://www.jstor.org/stable/27867261
Characterization of Research Mentorship During Medical School for Future Radiation Oncology Trainees
Autor:
Marisa Palmeri, MBS, Kristy Bono, MS, Austin Huang, BSA, Jillian R. Gunther, MD, PhD, Malcolm D. Mattes, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 5, Pp 101460- (2024)
Purpose: Medical student access to radiation oncology (RO) research opportunities is important for stimulating interest in the specialty. The purpose of this study was to assess the publication record during medical school of students who ultimately
Externí odkaz:
https://doaj.org/article/efb61653f68a4428892dc5924d318d09
Training doctoral students in critical thinking and experimental design using problem-based learning
Publikováno v:
BMC Medical Education, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Traditionally, doctoral student education in the biomedical sciences relies on didactic coursework to build a foundation of scientific knowledge and an apprenticeship model of training in the laboratory of an established investiga
Externí odkaz:
https://doaj.org/article/406642e8dd8348eea0be5691a2b02cda
Autor:
Kelsey L. Corrigan, Bryce B. Reeve, John M. Salsman, Elizabeth J. Siembida, Grace L. Smith, Maria C. Swartz, Kamaria L. Lee, Faraz Afridi, Lauren M. Andring, Andrew J. Bishop, Jillian R. Gunther, J. Andrew Livingston, Susan K. Peterson, Michael Roth
Publikováno v:
Cancer Medicine, Vol 12, Iss 13, Pp 14157-14170 (2023)
Abstract Background Radiation therapy (RT) is a common treatment for adolescents and young adults (AYAs, 15–39 years old) with cancer; however, it may cause toxicities that affect health‐related quality‐of‐life (HRQOL). Thus, we assessed HRQO
Externí odkaz:
https://doaj.org/article/0bb7ea58958e42359df1aada4803a8bc
Autor:
Susan Y. Wu, MD, Penny Q. Fang, MD, MBA, Ethan B. Wang, BA, Sairah Ahmed, MD, Madeleine Duvic, MD, Preetesh Jain, MD, Luis E. Malpica Castillo, MD, Ranjit Nair, MD, Raphael E. Steiner, MD, Paolo Strati, MD, Auris O. Huen, MD, PharmD, Swaminathan P. Iyer, MD, Chelsea C. Pinnix, MD, PhD, Bouthaina S. Dabaja, MD, Jillian R. Gunther, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 6, Pp 101279- (2023)
Purpose: Purpose: Radiation therapy (RT) and the antibody-drug conjugate brentuximab vedotin (BV) are standard-of-care treatment options for patients with certain B and T-cell lymphomas; however, there are limited data exploring the safety of concurr
Externí odkaz:
https://doaj.org/article/d902d9f49c7047199b12871407803f0e
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 38, Iss , Pp 53-56 (2023)
Total skin electron beam therapy (TSEBT) is effective for patients with refractory or diffuse skin involvement of cutaneous T cell lymphomas (CTCL). A common concern for patients undergoing TSEBT is the development of alopecia. Patients are already b
Externí odkaz:
https://doaj.org/article/a617e22a33604664a983e4cf4c125e70
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.